Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.

Published

Journal Article (Review)

There are wide disparities in breast cancer-specific survival by patient sociodemographic characteristics. Women of lower income, for instance, have higher relapse and death rates from breast cancer. One possible contributing factor for this disparity is low use of adjuvant endocrine therapy-an extremely efficacious therapy in women with early stage, hormone receptor positive breast cancer, the most common subtype of breast cancer. Alone, adjuvant endocrine therapy decreases breast cancer recurrence by 50% and death by 30%. Data suggest that low use of adjuvant endocrine therapy is a potentially important and modifiable risk factor for poor outcome in low-income breast cancer patients.

Full Text

Duke Authors

Cited Authors

  • Ursem, CJ; Bosworth, HB; Shelby, RA; Hwang, W; Anderson, RT; Kimmick, GG

Published Date

  • May 2015

Published In

Volume / Issue

  • 24 / 5

Start / End Page

  • 403 - 408

PubMed ID

  • 25884292

Pubmed Central ID

  • 25884292

Electronic International Standard Serial Number (EISSN)

  • 1931-843X

International Standard Serial Number (ISSN)

  • 1540-9996

Digital Object Identifier (DOI)

  • 10.1089/jwh.2014.4982

Language

  • eng